Pharmacokinetic-Pharmacodynamic Analyses for Efficacy of Ceftaroline Fosamil in Patients with Community-Acquired Bacterial Pneumonia

Pharmacokinetic-pharmacodynamic (PK-PD) analyses for efficacy using phase III trial data from patients treated with a ceftaroline fosamil dosing regimen of 600 mg intravenously (i.v.) every 12 h (q12h) for 5 to 7 days for community-acquired bacterial pneumonia (CABP) were conducted. High clinical an...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Bhavnani, Sujata M., Hammel, Jeffrey P., Van Wart, Scott A., Rubino, Christopher M., Reynolds, Daniel K., Forrest, Alan, Khariton, Tatiana, Friedland, H. David, Riccobene, Todd A., Ambrose, Paul G.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Society for Microbiology 2013
Pynciau:
Pharmacology
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3837912/
https://ncbi.nlm.nih.gov/pubmed/24041902
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01748-13
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg